Enterprise Workshop – 2 December 2019, Kigali

Are you an African researcher or a clinician working on HIV vaccine research and development (R&D)? Are you interested in sharing your experience and the challenges you face in your daily work? Are you keen to develop practical solutions to support African researchers towards the development of a safe and effective HIV vaccine?

The Global HIV Vaccine Enterprise hosted by the International AIDS Society (IAS) invites you to apply to attend an interactive half-day workshop in Kigali. The objective is to strengthen the participation and contribution of African researchers in the global effort towards a safe and effective HIV vaccine.

The workshop will provide an opportunity for participants to share their experience of conducting research (from bench to clinic) in African countries, identifying areas where concrete and realistic action could make a difference towards encouraging, supporting and facilitating African-led R&D towards the development of a safe and effective HIV vaccine.

The workshop will take place on Monday 2 December in Kigali, Rwanda ahead of the ICASA conference  (Registration at the ICASA conference is not needed). Some support will be available to attend the workshop. Eligibility criteria will apply to ensure a diversity of stakeholders. Space is limited to 25 attendees.

The deadline for applications is 4th of November.

Eligible applicants

The applicant must be from an organisation with an established legal entity in Africa and (1) be a post-doctoral scientist / clinician, having been awarded a PhD or MD by a recognized university, (2) work in a field of direct relevance to the development of an HIV vaccine and (3) have been an active researchers/clinician for at least two years following award of their degree.

Applications closed.

WP Twitter Auto Publish Powered By : XYZScripts.com